Search
for
Sort by
Research 61–90 of 317
- Drug-Induced Hair Disorders
- Cutaneous Reactions to Drugs
- Exploring the Drug Repurposing Versatility of Valproic Acid as a Multifunctional Regulator of Innate and Adaptive Immune Cells
- Drug eruptions in dermatology
- Repositioning Old Drugs for New Battles: The Expanding Role of Drug Repurposing in Cancer, Inflammation, and Metabolic Disease.
- Drug-induced male infertility: a real-world study using FAERS and EudraVigilance databases
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Drug Reactions Affecting Hair: Diagnosis
- Hair Changes due to Drugs
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Effectiveness and Adverse Drug Reaction Mechanisms Associated with Valproic Acid Use: A Cross-Sectional Prospective Study in Indonesia
- PD29-07 DRUGS ASSOCIATED THE MOST WITH MALE-FACTOR INFERTILITY: ASSESSMENT OF THE 2010-2020 FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASE
- Melatonin Receptors and Their Role in Human Diseases
- Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report
- Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery
- Exploring the Versatility of Microemulsions in Cutaneous Drug Delivery: Opportunities and Challenges
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database
- Effects of local and systemic medications on eye health: Adverse reactions
- Encapsulation of Curcumin in Polystyrene-Based Nanoparticles—Drug Loading Capacity and Cytotoxicity
- Incretin-Based Drugs for Obesity: Common and Drug-Specific Reporting Patterns of Adverse Drug Reactions—A Comparative Disproportionality Analysis Using EudraVigilance Reports Integrating SmPC Data
- Alopecia and hirsutism*
- ROSMARINUS OFFICINALIS: HAIR, SKIN AND OTHER POSSIBLE THERAPEUTIC ACTIVITIES
- Pharmacovigilance-based drug repurposing: searching for putative drugs with hypohidrosis or anhidrosis adverse events for use against hyperhidrosis
- Toxic Epidermal Necrolysis
- Adverse Cutaneous Reactions to Antidepressants
- Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy
- Phenytoin associated alopecia: drug induced lupus.
- Lithium: one drug, five complications